Dr Reddy’s gets DCGI nod for Covid-19 vaccine Sputnik V Phase III trials

The Times of India reports:
HYDERABAD: Dr Reddy's Laboratories has received the Drug Controller General of India ( DCGI) to conduct Phase III trials of Russian Covid-19 vaccine Sputnik V in India, the company informed the bourses on Friday. "The Phase III study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India," Dr Reddy's said is a late night regulatory filing.
Go deeper (2 min. read) →     FAQ    Watch Live TV News
Younews is India's best trending news aggregator. We help you discover latest trending content and the most popular stories from all sites across India. Add Younews to your home screen for easy, fast access to latest trending news. Use the 3-dot menu of your browser app and click "Install/add to home screen".

LUV

SAD

WOW

MEH

GRR

HUH

LOL

0

0

0

0

0

0

0

This story is trending. Share it.